WASHINGTON (WKRC) – The Food and Drug Administration (FDA) has upgraded a recall of commonly prescribed medication.
The recall of approximately 160,630 bottles of levothyroxine sodium tablets, a thyroid medication, was issued with concerns over subpotency. The prescription-only drug has been classified as Class II, indicating a moderate risk to public health, according to multiple notices issued by the agency.
The FDA stated that the medication’s content is “below the approved specification,” leading to the recall.
Levothyroxine sodium is used to treat hypothyroidism, a condition where the thyroid gland does not produce enough hormones. The drug acts as a replacement therapy to supplement natural thyroid levels and is one of the most widely prescribed medications in the United States.
The recalled tablets come in various potencies and bottle sizes, including 25 mcg, 50 mcg, 100 mcg, 112 mcg, 150 mcg, and 175 mcg, with specific lot numbers and expiration dates available here.
Source link